Please Wait.....
Report
Acute Ischemic Stroke Diagnosis Market By Technology (Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, Others) , By End User (Hospitals and Clinics, Ambulatory Surgery Centers, Diagnostic Laboratories and Imaging Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 228 Pages I Allied Market Research
Acute Ischemic Stroke Diagnosis Market
The acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.
Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due toa thrombus or embolus, resulting inbrain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.
Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labelingare trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.
However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.
Segment Review
The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.
Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.
Region wise, North America is poised to be the highest revenue generator by 2023.
Competition Analysis
The major players operating in theglobal acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Technology
- Computed Tomography
- Magnetic Resonance Imaging
- Carotid Ultrasound
- Cerebral Angiography
- Electrocardiography
- Echocardiography
- Others
By End User
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Diagnostic Laboratories and Imaging Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Koninklijke Philips N.V.
- GE Healthcare
- Canon Inc.
- Simens
- Terumo Corporation
- Stryker
- Fujifilm Holdings Corporation
- Samsung Electronics Co. Ltd
- F. Hoffmann-La Roche Ltd
- Boehringer Ingelheim International GmbH
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ADVANCE DIRECTIVES MARKET, BY COMPONENT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Component
4.2. Software
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Services
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS
5.1. Market Overview
5.1.1 Market Size and Forecast, By Demographics
5.2. Elderly Population (65 Yrs Above)
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Middle Aged (40-60 Yrs)
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Young Adults (18-39 Yrs)
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ADVANCE DIRECTIVES MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Payers
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Providers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: ADVANCE DIRECTIVES MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Component
7.2.3. Market Size and Forecast, By Demographics
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Advance Directives Market
7.2.6.1. Market Size and Forecast, By Component
7.2.6.2. Market Size and Forecast, By Demographics
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Advance Directives Market
7.2.7.1. Market Size and Forecast, By Component
7.2.7.2. Market Size and Forecast, By Demographics
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Advance Directives Market
7.2.8.1. Market Size and Forecast, By Component
7.2.8.2. Market Size and Forecast, By Demographics
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Component
7.3.3. Market Size and Forecast, By Demographics
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Advance Directives Market
7.3.6.1. Market Size and Forecast, By Component
7.3.6.2. Market Size and Forecast, By Demographics
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Advance Directives Market
7.3.7.1. Market Size and Forecast, By Component
7.3.7.2. Market Size and Forecast, By Demographics
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Advance Directives Market
7.3.8.1. Market Size and Forecast, By Component
7.3.8.2. Market Size and Forecast, By Demographics
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Advance Directives Market
7.3.9.1. Market Size and Forecast, By Component
7.3.9.2. Market Size and Forecast, By Demographics
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Advance Directives Market
7.3.10.1. Market Size and Forecast, By Component
7.3.10.2. Market Size and Forecast, By Demographics
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Advance Directives Market
7.3.11.1. Market Size and Forecast, By Component
7.3.11.2. Market Size and Forecast, By Demographics
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Component
7.4.3. Market Size and Forecast, By Demographics
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Advance Directives Market
7.4.6.1. Market Size and Forecast, By Component
7.4.6.2. Market Size and Forecast, By Demographics
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Advance Directives Market
7.4.7.1. Market Size and Forecast, By Component
7.4.7.2. Market Size and Forecast, By Demographics
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Advance Directives Market
7.4.8.1. Market Size and Forecast, By Component
7.4.8.2. Market Size and Forecast, By Demographics
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Advance Directives Market
7.4.9.1. Market Size and Forecast, By Component
7.4.9.2. Market Size and Forecast, By Demographics
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Advance Directives Market
7.4.10.1. Market Size and Forecast, By Component
7.4.10.2. Market Size and Forecast, By Demographics
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Advance Directives Market
7.4.11.1. Market Size and Forecast, By Component
7.4.11.2. Market Size and Forecast, By Demographics
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Component
7.5.3. Market Size and Forecast, By Demographics
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Advance Directives Market
7.5.6.1. Market Size and Forecast, By Component
7.5.6.2. Market Size and Forecast, By Demographics
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Advance Directives Market
7.5.7.1. Market Size and Forecast, By Component
7.5.7.2. Market Size and Forecast, By Demographics
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Advance Directives Market
7.5.8.1. Market Size and Forecast, By Component
7.5.8.2. Market Size and Forecast, By Demographics
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Advance Directives Market
7.5.9.1. Market Size and Forecast, By Component
7.5.9.2. Market Size and Forecast, By Demographics
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. West Health
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. MyDirectives, Inc.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Aledade
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. VyncaCare
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. WiserCare
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Sharp HealthCare
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Vital Decisions LLC
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Affirm Health
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Thanacare
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Honor My Decisions LLC
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 2. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR CAROTID ULTRASOUND, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR CEREBRAL ANGIOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR ELECTROCARDIOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR ECHOCARDIOGRAPHY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 10. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR DIAGNOSTIC LABORATORIES AND IMAGING CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. U.S. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 19. U.S. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 21. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 22. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 23. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 25. EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 26. EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 28. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 30. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 31. UK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 32. UK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 34. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 35. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 36. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. REST OF EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 38. REST OF EUROPE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 40. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 41. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 43. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 44. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 45. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 47. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 49. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 50. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 51. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. REST OF ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 53. REST OF ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 54. LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 55. LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 56. LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 58. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 60. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 63. REST OF LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 64. REST OF LAMEA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 65. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 66. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 67. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 68. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 69. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 70. GE HEALTHCARE: KEY EXECUTIVES
TABLE 71. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 72. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 73. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 74. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75. CANON INC.: KEY EXECUTIVES
TABLE 76. CANON INC.: COMPANY SNAPSHOT
TABLE 77. CANON INC.: OPERATING SEGMENTS
TABLE 78. CANON INC.: PRODUCT PORTFOLIO
TABLE 79. CANON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 80. SIMENS: KEY EXECUTIVES
TABLE 81. SIMENS: COMPANY SNAPSHOT
TABLE 82. SIMENS: OPERATING SEGMENTS
TABLE 83. SIMENS: PRODUCT PORTFOLIO
TABLE 84. SIMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 85. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 86. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 87. TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 88. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 89. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. STRYKER: KEY EXECUTIVES
TABLE 91. STRYKER: COMPANY SNAPSHOT
TABLE 92. STRYKER: OPERATING SEGMENTS
TABLE 93. STRYKER: PRODUCT PORTFOLIO
TABLE 94. STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. FUJIFILM HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 96. FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 97. FUJIFILM HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 98. FUJIFILM HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 99. FUJIFILM HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. SAMSUNG ELECTRONICS CO. LTD: KEY EXECUTIVES
TABLE 101. SAMSUNG ELECTRONICS CO. LTD: COMPANY SNAPSHOT
TABLE 102. SAMSUNG ELECTRONICS CO. LTD: OPERATING SEGMENTS
TABLE 103. SAMSUNG ELECTRONICS CO. LTD: PRODUCT PORTFOLIO
TABLE 104. SAMSUNG ELECTRONICS CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
TABLE 106. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 107. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
TABLE 108. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 109. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY EXECUTIVES
TABLE 111. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
TABLE 112. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: OPERATING SEGMENTS
TABLE 113. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO
TABLE 114. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALACUTE ISCHEMIC STROKE DIAGNOSIS MARKET
FIGURE 10. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION, BY TECHNOLOGY
FIGURE 11. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR CAROTID ULTRASOUND, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR CEREBRAL ANGIOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR ELECTROCARDIOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR ECHOCARDIOGRAPHY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION, BY END USER
FIGURE 19. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR DIAGNOSTIC LABORATORIES AND IMAGING CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 27. COMPETITIVE DASHBOARD
FIGURE 28. COMPETITIVE HEATMAP: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET
FIGURE 29. TOP PLAYER POSITIONING, 2023
FIGURE 30. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. CANON INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. CANON INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. CANON INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. SIMENS: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. SIMENS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. SIMENS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. TERUMO CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. STRYKER: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. STRYKER: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. STRYKER: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. FUJIFILM HOLDINGS CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. FUJIFILM HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. SAMSUNG ELECTRONICS CO. LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. SAMSUNG ELECTRONICS CO. LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. SAMSUNG ELECTRONICS CO. LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 55. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 57. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 58. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 59. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security